The abstract is read at the publisher; the summary is JClub's.
A consistent adiposity metabolic signature of 242 metabolites was identified across two weight-loss interventions, and its disease links differed by outcome in MR analyses.
- Why it matters: Obesity’s disease risk mechanisms are unclear, and single study types can be biased; triangulating intervention, observational metabolomics, and genetic evidence can reveal robust pathways.
- What they did: Mass spectrometry and NMR metabolomics from the DiRECT and By-Band-Sleeve weight-loss trials were integrated with Mendelian randomisation of lifetime BMI effects on metabolites, then instrumented metabolite clusters were tested against heart failure, osteoarthritis, and kidney cancer.
- The result: LDL measures were strongly linked to higher heart failure risk, HDL cholesterol-enrichment traits were protective, and dysfunctional HDL remodelling markers increased risk; osteoarthritis showed opposite-direction lipoprotein associations plus glycine pathway signals, while kidney cancer yielded only 5-methyluridine and ursodeoxycholate associations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.